MLSS Quote, Financials, Valuation and Earnings

Biolase has a net margin of -58.13% compared to Milestone Scientific's net margin of -13.16%. Milestone Scientific's return on equity of -61.33% beat Biolase's return on equity of -21668.17%.

Milestone Scientific has a consensus price target of --, signalling upside risk potential of 114.65%. On the other hand Biolase has an analysts' consensus of $1.2000 which suggests that it could grow by 25541.03%. Given that Biolase has higher upside potential than Milestone Scientific, analysts believe Biolase is more attractive than Milestone Scientific.

Milestone Scientific has a beta of 1.409, which suggesting that the stock is 40.929% more volatile than S&P 500. In comparison Biolase has a beta of 0.817, suggesting its less volatile than the S&P 500 by 18.311%.

Milestone Scientific has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Biolase offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Milestone Scientific pays -- of its earnings as a dividend. Biolase pays out -- of its earnings as a dividend.

Milestone Scientific quarterly revenues are $2.5M, which are smaller than Biolase quarterly revenues of $10.9M. Milestone Scientific's net income of -$1.5M is lower than Biolase's net income of -$1.4M. Notably, Milestone Scientific's price-to-earnings ratio is -- while Biolase's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Milestone Scientific is 8.74x versus 0.00x for Biolase. Usually stocks with elevated PS ratios are considered overvalued.

Envista Holdings has a net margin of -58.13% compared to Milestone Scientific's net margin of 0.18%. Milestone Scientific's return on equity of -61.33% beat Envista Holdings's return on equity of -32.33%.

Milestone Scientific has a consensus price target of --, signalling upside risk potential of 114.65%. On the other hand Envista Holdings has an analysts' consensus of $21.33 which suggests that it could grow by 25.71%. Given that Milestone Scientific has higher upside potential than Envista Holdings, analysts believe Milestone Scientific is more attractive than Envista Holdings.

Milestone Scientific has a beta of 1.409, which suggesting that the stock is 40.929% more volatile than S&P 500. In comparison Envista Holdings has a beta of 1.326, suggesting its more volatile than the S&P 500 by 32.59%.

Milestone Scientific has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Envista Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Milestone Scientific pays -- of its earnings as a dividend. Envista Holdings pays out -- of its earnings as a dividend.

Milestone Scientific quarterly revenues are $2.5M, which are smaller than Envista Holdings quarterly revenues of $652.9M. Milestone Scientific's net income of -$1.5M is lower than Envista Holdings's net income of $1.2M. Notably, Milestone Scientific's price-to-earnings ratio is -- while Envista Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Milestone Scientific is 8.74x versus 1.17x for Envista Holdings. Usually stocks with elevated PS ratios are considered overvalued.

Sonendo has a net margin of -58.13% compared to Milestone Scientific's net margin of --. Milestone Scientific's return on equity of -61.33% beat Sonendo's return on equity of --.

Milestone Scientific has a consensus price target of --, signalling upside risk potential of 114.65%. On the other hand Sonendo has an analysts' consensus of -- which suggests that it could fall by --. Given that Milestone Scientific has higher upside potential than Sonendo, analysts believe Milestone Scientific is more attractive than Sonendo.

Milestone Scientific has a beta of 1.409, which suggesting that the stock is 40.929% more volatile than S&P 500. In comparison Sonendo has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Milestone Scientific has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Sonendo offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Milestone Scientific pays -- of its earnings as a dividend. Sonendo pays out -- of its earnings as a dividend.

Milestone Scientific quarterly revenues are $2.5M, which are larger than Sonendo quarterly revenues of --. Milestone Scientific's net income of -$1.5M is higher than Sonendo's net income of --. Notably, Milestone Scientific's price-to-earnings ratio is -- while Sonendo's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Milestone Scientific is 8.74x versus -- for Sonendo. Usually stocks with elevated PS ratios are considered overvalued.

Dentsply Sirona has a net margin of -58.13% compared to Milestone Scientific's net margin of -47.51%. Milestone Scientific's return on equity of -61.33% beat Dentsply Sirona's return on equity of -32.39%.

Milestone Scientific has a consensus price target of --, signalling upside risk potential of 114.65%. On the other hand Dentsply Sirona has an analysts' consensus of $20.20 which suggests that it could grow by 33.96%. Given that Milestone Scientific has higher upside potential than Dentsply Sirona, analysts believe Milestone Scientific is more attractive than Dentsply Sirona.

Milestone Scientific has a beta of 1.409, which suggesting that the stock is 40.929% more volatile than S&P 500. In comparison Dentsply Sirona has a beta of 0.976, suggesting its less volatile than the S&P 500 by 2.383%.

Milestone Scientific has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Dentsply Sirona offers a yield of 4.29% to investors and pays a quarterly dividend of $0.16 per share. Milestone Scientific pays -- of its earnings as a dividend. Dentsply Sirona pays out -13.85% of its earnings as a dividend.

Milestone Scientific quarterly revenues are $2.5M, which are smaller than Dentsply Sirona quarterly revenues of $905M. Milestone Scientific's net income of -$1.5M is higher than Dentsply Sirona's net income of -$430M. Notably, Milestone Scientific's price-to-earnings ratio is -- while Dentsply Sirona's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Milestone Scientific is 8.74x versus 0.80x for Dentsply Sirona. Usually stocks with elevated PS ratios are considered overvalued.